Source comparison
GHRP-2 vs Ipamorelin: The Research Community Consensus
The GHRP-2 vs Ipamorelin comparison has produced a clear consensus in the research community: there is no universally “better” compound — only a better fit for a specific research question. Ipamorelin has become the default choice for researchers who prioritiz
This comparison does not assign a generated winner or score.
- The GHRP-2 vs Ipamorelin comparison has produced a clear consensus in the research community: there is no universally “better” compound — only a better fit for a specific research question. Ipamorelin has become the default choice for researchers who prioritize clean data without hormonal confounders. GHRP-2 is chosen by researchers who need maximum GH amplitude and are comfortable managing the associated cortisol and prolactin effects. The CJC-1295/Ipamorelin Blend ($65.99 at PSPeptides) has become the most popular pre-formulated option for researchers who want both GHRH synergy and GHRP selectivity.
- The GHRP-2 vs Ipamorelin comparison will continue to be relevant because the potency-selectivity tradeoff is inherent to the GHS-R1a pharmacology — no compound has yet been designed that provides GHRP-2-level GH amplitude with Ipamorelin-level selectivity. Until such a compound is developed, the GHRP-2 vs Ipamorelin comparison remains the defining choice in GH peptide research.